Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Paoletti

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|August 13, 2009
A comparison of model choices for the Continual Reassessment Method in phase I cancer trialsX Paoletti, A Kramar
British Journal of Anaesthesia|February 20, 2007
Consequences of running more operating theatres than anaesthetists to staff them: a stochastic simulation studyX Paoletti, J Marty
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Phase I-II trial designs: how early should efficacy guide the dose recommendation process?X Paoletti, S Postel-Vinay
Human Reproduction (Oxford, England)|July 24, 2004
Breast cancer risk associated with being treated for infertility: results from the French E3N cohort studyE Gauthier, X Paoletti, F Clavel-Chapelon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2015
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trialsX Paoletti, M Ezzalfani, C Le Tourneau
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|February 16, 2005
[Reliability of the KT-1000 arthrometer (Medmetric) for measuring anterior knee laxity: comparison with Telos in 147 knees]P Boyer, P Djian, P Christel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
Designs of drug-combination phase I trials in oncology: a systematic review of the literatureM-K Riviere, C Le Tourneau, X Paoletti, et al.
British Journal of Cancer|January 28, 2012
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agentsC Le Tourneau, V Servois, V Diéras, et al.
Bulletin Du Cancer|January 12, 2011
[Dose finding methods for targeted agents: new perspectives]X Paoletti, S Postel-Vinay, V Servois, et al.
ESMO Open|January 3, 2022
Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patientsT Samaille, C Moreau Bachelard, E Coquan, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|August 13, 2009
A comparison of model choices for the Continual Reassessment Method in phase I cancer trialsX Paoletti, A Kramar
British Journal of Anaesthesia|February 20, 2007
Consequences of running more operating theatres than anaesthetists to staff them: a stochastic simulation studyX Paoletti, J Marty
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Phase I-II trial designs: how early should efficacy guide the dose recommendation process?X Paoletti, S Postel-Vinay
Human Reproduction (Oxford, England)|July 24, 2004
Breast cancer risk associated with being treated for infertility: results from the French E3N cohort studyE Gauthier, X Paoletti, F Clavel-Chapelon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2015
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trialsX Paoletti, M Ezzalfani, C Le Tourneau
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|February 16, 2005
[Reliability of the KT-1000 arthrometer (Medmetric) for measuring anterior knee laxity: comparison with Telos in 147 knees]P Boyer, P Djian, P Christel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
Designs of drug-combination phase I trials in oncology: a systematic review of the literatureM-K Riviere, C Le Tourneau, X Paoletti, et al.
British Journal of Cancer|January 28, 2012
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agentsC Le Tourneau, V Servois, V Diéras, et al.
Bulletin Du Cancer|January 12, 2011
[Dose finding methods for targeted agents: new perspectives]X Paoletti, S Postel-Vinay, V Servois, et al.
ESMO Open|January 3, 2022
Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patientsT Samaille, C Moreau Bachelard, E Coquan, et al.
Pageof 3